Ahmed G. Alghamdi

Riyadh, Saudi Arabia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Patient Preferences for Virtual Versus In-Person Care in Inflammatory Bowel Disease: A Cross-Sectional Study.

Patient Preferences for Virtual Versus In-Person Care in Inflammatory Bowel Disease: A Cross-Sectional Study.

Journal: Telemedicine journal and e-health : the official journal of the American Telemedicine Association

Published: July 03, 2026

Methanol-Related Fatalities in Jeddah, Saudi Arabia: A 5-Year Post-Mortem Multi-Matrix Study.

Methanol-Related Fatalities in Jeddah, Saudi Arabia: A 5-Year Post-Mortem Multi-Matrix Study.

Journal: Toxics

Published: February 17, 2026

Patterns and predictors of biologic therapy switching in inflammatory bowel disease at a tertiary care center: A retrospective observational study.

Patterns and predictors of biologic therapy switching in inflammatory bowel disease at a tertiary care center: A retrospective observational study.

Journal: Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association

Published: May 17, 2025

Coexisting autoimmune disorders among patients with inflammatory bowel disease at a tertiary center in Saudi Arabia: A cross-sectional study.

Coexisting autoimmune disorders among patients with inflammatory bowel disease at a tertiary center in Saudi Arabia: A cross-sectional study.

Journal: Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association

Published: July 15, 2024

Prevalence and clinical implications of anti-drug antibody formation and serum drug levels among patients with IBD receiving anti-TNF therapy: A cross-sectional study.

Prevalence and clinical implications of anti-drug antibody formation and serum drug levels among patients with IBD receiving anti-TNF therapy: A cross-sectional study.

Journal: Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association

Published: July 08, 2024

Prevalence and Risk Factors of Cytomegalovirus Colitis in Inflammatory Bowel Disease Patients in Riyadh, Saudi Arabia: A Tertiary Center Experience.

Prevalence and Risk Factors of Cytomegalovirus Colitis in Inflammatory Bowel Disease Patients in Riyadh, Saudi Arabia: A Tertiary Center Experience.

Journal: Saudi journal of medicine & medical sciences

Published: April 13, 2023

Prevalence of Classical Extraintestinal Manifestations among Inflammatory Bowel Disease Patients in Saudi Arabia: A Single Tertiary Center Experience.

Prevalence of Classical Extraintestinal Manifestations among Inflammatory Bowel Disease Patients in Saudi Arabia: A Single Tertiary Center Experience.

Journal: Saudi journal of medicine & medical sciences

Published: March 27, 2023

The efficacy of Elbasvir/Grazoprevir fixed-dose combination for 8 weeks in HCV treatment and health-related quality of life (HRQoL) in treatment-naïve, non-cirrhotic, genotype 4-infected patients (ELEGANT-4): A single-center, single-arm, open-label, phase 3 trial.

The efficacy of Elbasvir/Grazoprevir fixed-dose combination for 8 weeks in HCV treatment and health-related quality of life (HRQoL) in treatment-naïve, non-cirrhotic, genotype 4-infected patients (ELEGANT-4): A single-center, single-arm, open-label, phase 3 trial.

Journal: Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association

Published: February 10, 2022

Showing 1-8 of 8

Last Updated: 09/26/2026